VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,764,780 | -8.7% | 252,183 | +2.4% | 0.11% | -9.4% |
| Q2 2023 | $7,412,972 | +4.2% | 246,196 | +12.0% | 0.12% | -0.8% |
| Q1 2023 | $7,110,832 | -10.3% | 219,809 | -20.5% | 0.12% | -18.1% |
| Q4 2022 | $7,928,526 | +31.2% | 276,641 | +10.4% | 0.14% | -10.0% |
| Q3 2022 | $6,043,000 | -8.7% | 250,549 | +3.6% | 0.16% | +6.0% |
| Q2 2022 | $6,621,000 | -29.3% | 241,829 | -0.9% | 0.15% | -19.3% |
| Q1 2022 | $9,362,000 | +23.4% | 244,119 | +3.1% | 0.19% | +21.4% |
| Q4 2021 | $7,587,000 | +15.9% | 236,886 | +6.6% | 0.15% | +21.3% |
| Q3 2021 | $6,548,000 | +6.5% | 222,181 | +22.8% | 0.13% | -13.0% |
| Q2 2021 | $6,148,000 | +30.4% | 180,927 | +24.7% | 0.15% | +12.3% |
| Q1 2021 | $4,715,000 | +50.4% | 145,068 | +66.7% | 0.13% | +30.0% |
| Q4 2020 | $3,134,000 | -4.8% | 87,020 | +3.5% | 0.10% | -19.4% |
| Q3 2020 | $3,292,000 | +9.2% | 84,078 | +2.3% | 0.12% | -3.9% |
| Q2 2020 | $3,014,000 | -8.9% | 82,167 | -42.8% | 0.13% | -27.5% |
| Q1 2020 | $3,308,000 | +25.4% | 143,564 | +59.5% | 0.18% | +57.5% |
| Q4 2019 | $2,637,000 | +51.1% | 90,005 | +38.7% | 0.11% | +46.8% |
| Q3 2019 | $1,745,000 | +28.1% | 64,913 | +22.8% | 0.08% | +26.2% |
| Q2 2019 | $1,362,000 | -38.5% | 52,859 | -46.9% | 0.06% | -44.5% |
| Q1 2019 | $2,216,000 | +9.8% | 99,561 | +3.9% | 0.11% | -6.8% |
| Q4 2018 | $2,019,000 | +19.6% | 95,838 | +6.1% | 0.12% | +42.2% |
| Q3 2018 | $1,688,000 | -15.6% | 90,336 | +0.3% | 0.08% | -27.8% |
| Q2 2018 | $2,001,000 | +3.0% | 90,027 | +1.7% | 0.12% | -1.7% |
| Q1 2018 | $1,942,000 | -3.6% | 88,551 | +2.1% | 0.12% | -4.9% |
| Q4 2017 | $2,014,000 | +0.6% | 86,760 | -1.0% | 0.12% | +1.7% |
| Q3 2017 | $2,002,000 | +2.6% | 87,674 | -0.5% | 0.12% | -0.8% |
| Q2 2017 | $1,951,000 | +8.9% | 88,136 | +11.9% | 0.12% | +1.7% |
| Q1 2017 | $1,792,000 | +16.1% | 78,733 | +5.7% | 0.12% | +3.4% |
| Q4 2016 | $1,544,000 | +11.6% | 74,487 | +42.2% | 0.12% | +9.4% |
| Q3 2016 | $1,383,000 | +8.7% | 52,395 | +14.5% | 0.11% | +7.1% |
| Q2 2016 | $1,272,000 | – | 45,745 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |